Most Recent Articles about NVO
Vertex (VRTX) Inks All-Cash Deal to Acquire Semma for $950M http://www.zacks.com/stock/news/501399/vertex-vrtx-inks-all-cash-deal-to-acquire-semma-for-%24950m?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-501399 Sep 04, 2019 - Vertex (VRTX) inks an all-cash deal to buy privately-held Semma Therapeutic. The acquisition will add pre-clinical type I diabetes candidates to its pipeline.
Pharma Stock Roundup: PFE to Buy ARRY, RHHBY, MRK, AZN Drugs Get Regulatory Nod http://www.zacks.com/stock/news/432688/pharma-stock-roundup-pfe-to-buy-arry-rhhby-mrk-azn-drugs-get-regulatory-nod?cid=CS-ZC-FT-432688 Jun 21, 2019 - Pfizer (PFE) announces definitive deal buy Array BioPharma. Merck (MRK), Roche (RHHBY) and AstraZeneca (AZN) win approvals for new drugs/line extensions.
Gilead (GILD) Teams Up With Nurix for Cancer and Other Drugs http://www.zacks.com/stock/news/432004/gilead-gild-teams-up-with-nurix-for-cancer-and-other-drugs?cid=CS-ZC-FT-432004 Jun 20, 2019 - Gilead (GILD) collaborates with Nurix Therapeutics to leverage the proprietary drug discovery platform of the latter to identify novel agents that induce degradation of specified drug targets.

Related Companies

Name Exchange Price Mkt Cap
LLY Eli Lilly and Company NYSE $105.71 $113.53B
ABT Abbott Laboratories NYSE $67.67 $118.71B
SNY Sanofi NYSE $43.75 $109.14B
BMY Bristol-Myers Squibb Company NYSE $61.3 $100.03B
GSK GlaxoSmithKline PLC NYSE $39.21 $97.25B
Sector: Health Care > Industry: Major Pharmaceuticals